163 related articles for article (PubMed ID: 23062933)
1. A case of advanced cutaneous squamous cell carcinoma of the lower eyelid that was successfully treated with tegafur-gimeracil-oteracil potassium monotherapy.
Yamamoto Y; Nakai N; Wakabayashi Y; Okuzawa Y; Asai J; Takenaka H; Katoh N
J Am Acad Dermatol; 2012 Nov; 67(5):e233-4. PubMed ID: 23062933
[No Abstract] [Full Text] [Related]
2. Adjuvant chemotherapy with S-1 after curative chemoradiotherapy in patients with locoregionally advanced squamous cell carcinoma of the head and neck: Reanalysis of the ACTS-HNC study.
Kubota A; Nakatani E; Tsukahara K; Hasegawa Y; Takemura H; Terada T; Taguchi T; Nagahara K; Nakatani H; Yoshino K; Higaki Y; Iwae S; Beppu T; Hanamure Y; Tomita K; Kohno N; Kawabata K; Teramukai S; Fujii M;
PLoS One; 2018; 13(6):e0198391. PubMed ID: 29883463
[TBL] [Abstract][Full Text] [Related]
3. [Clinical efficacy of administration with S-1 alone for head and neck carcinoma].
Tsukuda M; Ishitoya J; Mikami Y; Matsuda H; Katori H; Horiuchi C; Taguchi T; Yoshida T; Toth G
Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():144-9. PubMed ID: 16897991
[TBL] [Abstract][Full Text] [Related]
4. How long should we continue S-1 as adjuvant chemotherapy for squamous cell carcinoma of the head and neck?
Hirai M; Orita Y; Takao S; Tachibana T; Marunaka H; Makihara S; Miki K; Noyama Y; Fuji S; Torigoe A; Sato Y; Nishizaki K
Acta Otolaryngol; 2015; 135(10):1079-85. PubMed ID: 26004393
[TBL] [Abstract][Full Text] [Related]
5. [Tegafur/gimeracil/oteracil (Teysuno), by oral administration].
Duh D; Warnez M
J Pharm Belg; 2013 Dec; (4):35-6. PubMed ID: 24449972
[No Abstract] [Full Text] [Related]
6. Feasibility and toxicity of adjuvant chemotherapy using S-1 granules for local advanced squamous cell carcinoma of the head and neck.
Suzuki S; Honda K; Sato T; Yamazaki K; Ishikawa K
J Chemother; 2015 Oct; 27(5):297-300. PubMed ID: 25971448
[TBL] [Abstract][Full Text] [Related]
7. Consecutive daily low-dose S-1 adjuvant chemotherapy after radical treatment for squamous cell carcinoma in head and neck cancer.
Furusaka T; Tanaka A; Matsuda H; Ikeda M
Acta Otolaryngol; 2011 Oct; 131(10):1099-103. PubMed ID: 21651316
[TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of S-1 chemotherapy in recurrent/metastatic head and neck cancer.
Suzuki S; Ishikawa K
J Infect Chemother; 2009 Oct; 15(5):335-9. PubMed ID: 19856075
[TBL] [Abstract][Full Text] [Related]
9. Erythematous lesion with peripheral purpura on the face.
Onoe A; Matsuura D; Terui T; Morikawa H; Fujii M; Ochiai T
Clin Exp Dermatol; 2019 Jun; 44(4):428-431. PubMed ID: 30264401
[No Abstract] [Full Text] [Related]
10. [Adjuvant chemotherapy with S-1 for advanced head and neck carcinoma].
Tsukuda M; Ishitoya J; Mikami Y; Matsuda H; Katori H; Horiuchi C; Taguchi T; Yoshida T; Toth G
Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():172-8. PubMed ID: 16897997
[TBL] [Abstract][Full Text] [Related]
11. Randomized scheduling feasibility study of S-1 for adjuvant chemotherapy in advanced head and neck cancer.
Tsukuda M; Kida A; Fujii M; Kono N; Yoshihara T; Hasegawa Y; Sugita M;
Br J Cancer; 2005 Oct; 93(8):884-9. PubMed ID: 16189518
[TBL] [Abstract][Full Text] [Related]
12. The efficacy and toxicity of S-1 and cisplatin as first-line chemotherapy in recurrent or metastatic head and neck squamous cell carcinoma.
Kim HS; Kim HR; Kim GM; Kim HS; Koh YW; Kim SH; Choi EC; Hong YK; Sung JH; Kim SM; Kim JH; Cho BC
Cancer Chemother Pharmacol; 2012 Oct; 70(4):539-46. PubMed ID: 22868340
[TBL] [Abstract][Full Text] [Related]
13. Feasibility of concurrent chemoradiotherapy with S-1 administered on alternate days for elderly patients with head and neck cancer.
Kogashiwa Y; Nagafuji H; Kohno N
Anticancer Res; 2012 Sep; 32(9):4035-40. PubMed ID: 22993356
[TBL] [Abstract][Full Text] [Related]
14. [Early phase II study of S-1 in patients with advanced head and neck cancer. S-1 Cooperative Study Group (Head and Neck Working Group)].
Inuyama Y; Kida A; Tsukuda M; Kohno N; Satake B
Gan To Kagaku Ryoho; 1998 Jul; 25(8):1151-8. PubMed ID: 9679577
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic effect of 1 M tegafur-0.4 M 5-chloro-2, 4-dihydroxypridine-1 M potassium oxonate (S-1) on head and neck squamous carcinoma cells.
Nishimura G; Yanoma S; Mizuno H; Satake K; Taguchi T; Ikeda Y; Tsukuda M
Cancer Lett; 2000 Oct; 159(1):1-7. PubMed ID: 10974399
[TBL] [Abstract][Full Text] [Related]
16. [Late phase II study of S-1 in patients with advanced head and neck cancer].
Inuyama Y; Kida A; Tsukuda M; Kohno N; Satake B;
Gan To Kagaku Ryoho; 2001 Oct; 28(10):1381-90. PubMed ID: 11681245
[TBL] [Abstract][Full Text] [Related]
17. Tegafur + gimeracil + oteracil. Just another fluorouracil precursor.
Prescrire Int; 2013 May; 22(138):122. PubMed ID: 23819172
[TBL] [Abstract][Full Text] [Related]
18. The Clinical Evaluation of Tegafur Gimeracil Oteracil Combined with THP and DDP for Second-Line Treatment of Advanced Cardiac Carcinoma.
Wang HF; Lv JQ
Cell Biochem Biophys; 2015 Jul; 72(3):695-9. PubMed ID: 25618173
[TBL] [Abstract][Full Text] [Related]
19. [Severe advanced lower gingival carcinoma effectively reduced by chemoradiation with S-1--report of a case].
Ishibashi M; Masuda N; Noguchi K; Moridera K; Nishimura N; Takayama T; Nishioji K; Urade M; Kogo M
Gan To Kagaku Ryoho; 2007 Nov; 34(11):1837-9. PubMed ID: 18030019
[TBL] [Abstract][Full Text] [Related]
20. [Postoperative chemotherapy with a novel oral anticancer drug composed of tegafur, gimeracil and oteracil potassium to curability C scirrhus type gastric cancer].
Iwatani Y; Shimada Y; Ohshima T; Kusunoki N; Yamazaki T; Miyazaki N
Gan To Kagaku Ryoho; 2001 Aug; 28(8):1129-32. PubMed ID: 11525030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]